Rifadin IV Intravenous and Risankizumab-rzaa topical
Determining the interaction of Rifadin IV Intravenous and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: Rifadin IV (Intravenous), Rifadin IV
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Rifadin IV Intravenous-Risedronate
- Rifadin IV Intravenous-Risedronate and Calcium
- Rifadin IV Intravenous-Risedronate Delayed Release
- Rifadin IV Intravenous-Risedronate Delayed-Release Tablets
- Rifadin IV Intravenous-Risedronate Sodium
- Rifadin IV Intravenous-Risedronate Tablets
- Risankizumab-rzaa topical-Rifamate
- Risankizumab-rzaa topical-Rifampin
- Risankizumab-rzaa topical-Rifampin and Isoniazid
- Risankizumab-rzaa topical-Rifampin Capsules
- Risankizumab-rzaa topical-Rifampin Injection
- Risankizumab-rzaa topical-Rifampin Intravenous